If I don’t understand something, I’ll just ask: Will the U.S. dollar exchange rate continue rising? Could it possibly reach 7.5?

If you regard Barclays Bank as highly competent, then go long on the U.S. dollar; if you see it as a clown, then go long on the RMB. But even a three-month forward target of 7.4 feels somewhat far-fetched to me.

Financial Public Lecture: Learning Investment Banking History from Barclays

What is ‘heavy-infantry banking’? Unlike light cavalry—relying on exceptional intellectual premium to secure the most prestigious, exclusive advisory deals—it wears heavy armor, boasts ample firepower, and maintains robust defensive capabilities. When transactions involve multi-billion-dollar bridge loans, cross-currency hedging instruments, and complex bookkeeping and distribution, its advantages become unmatched. The core of this ‘heavy-infantry approach’ lies in Barclays’ unique tripartite capability—balance-sheet strength + advisory consulting + market hedging—forming the very foundation of its position in the global investment banking arena. A simple, relatable example illustrates its core advantage: A major European corporation seeks to acquire a U.S. tech company valued at over $7 billion. Here, the client needs more than just a financial advisor capable of designing the transaction structure. It also requires: ・A multi-billion-dollar bridge loan to fund the acquisition; ・Subsequent bond issuance to refinance the bridge loan and optimize its capital structure; ・Hedging against foreign exchange and interest-rate risks to lock in future financing costs and mitigate volatility between the U.S. dollar and the euro; ・Regulatory compliance and investor distribution capabilities spanning both the U.S. and Europe. At this point, boutique investment banks can only design the transaction structure but cannot provide actual loan funding; regional European banks struggle with bond distribution and regulatory requirements in the U.S. market; and purely U.S.-based investment banks may lack Barclays’ deep roots in the European market. Barclays, however, delivers end-to-end solutions: its M&A team designs the transaction structure; its corporate banking division issues the bridge loan; its Debt Capital Markets (DCM) team arranges subsequent bond underwriting; its Global Markets division executes FX and interest-rate hedging; and its teams in both the U.K. and U.S. jointly handle regulatory compliance and investor communications across both jurisdictions. This is Barclays’ core competitive moat. While it may not win every top-tier pure-advisory mandate, whenever a deal demands real balance-sheet funding and transatlantic integrated capabilities, Barclays becomes the client’s first choice. This strategy has propelled Barclays to global leadership in several key areas: ・Debt Capital Markets (DCM): The crown jewel of Barclays—whether in investment-grade corporate bonds, sovereign debt, or financial institution bonds, it consistently ranks among the world’s top underwriters and dominates the European bond market. ・Leveraged Finance (LevFin) and Financial Sponsor Coverage: It maintains deep ties with global private equity giants—including Blackstone, KKR, and CVC—and stands as one of Wall Street’s most pivotal players in leveraged buyout (LBO) financing. ・Financial Institutions Group (FIG) Business: As a globally systemically important bank, it possesses unparalleled insight into financial institutions’ funding needs—earning top-tier global reputation for assisting banks and insurers in issuing AT1 and Tier 2 capital instruments. In an era where U.S. investment banks nearly monopolize the global elite league tables, Barclays—through this uniquely ‘heavy-infantry’ model—has tenaciously preserved the last seat for a European bank at the pinnacle of the global investment banking table. Lesson Five: Glory and Anxiety—the Blue Eagle at a Crossroads Of course, Barclays’ story has never been one of unbroken success. Today, it still stands at a historic crossroads—on one side, the glory of its dual transatlantic home markets; on the other, unavoidable challenges and anxieties.

Barclays sets USD 353 target for Air Products & Chemicals stock

Oct 15, 2026

Barclays initiated coverage on Air Products & Chemicals with an Overweight rating and a $353 price target, noting a USD 65.1 billion market cap prior to the Q4 2026 earnings release.

ad-hoc-news.de

Barclays sets USD 353 target for Air Products & Chemicals stock

ad-hoc-news.de

2026-09-30

Braskem SA Stock Price Target & Forecast

2026-10-08

Air Products and Chemicals Stock Trades at EUR 248.15

2026-10-15

Barclays sets USD 353 target for Air Products & Chemicals stock

Barclays sets USD 353 target for Air Products & Chemicals stock

FAQ